Reimbursement of pharmaceuticals: reference pricing versus health technology assessment.

Reimbursement of pharmaceuticals: reference pricing versus health technology assessment.

Item
http://www.wikidata.org/entity/Q34804377
From market access to patient access: overview of evidence-based approaches for the reimbursement and pricing of pharmaceuticals in 36 European countriesBalancing influence between actors in healthcare decision makingComprehensive taxonomy and worldwide trends in pharmaceutical policies in relation to country income status.Pharmaceutical policies in European countries in response to the global financial crisis.Comparing pharmaceutical pricing and reimbursement policies in Croatia to the European Union Member States.Budget Impact of Long-Acting Insulin Analogues: The Case in BrazilThe impact of reference pricing and extension of generic substitution on the daily cost of antipsychotic medication in Finland.The role of discounts and loss leaders in medicine procurement in Austrian hospitals - a primary survey of official and actual medicine pricesCritical Appraisal of Reimbursement List in Bosnia and Herzegovina.Differential pricing of new pharmaceuticals in lower income European countries.Using health technology assessment to assess the value of new medicines: results of a systematic review and expert consultation across eight European countries.How Can Pricing and Reimbursement Policies Improve Affordable Access to Medicines? Lessons Learned from European Countries.Early benefit assessment of pharmaceuticals in Germany: manufacturers' expectations versus the Federal Joint Committee's decisions.Similarities and differences between five European drug reimbursement systems.Adapting Pharmacoeconomics to Shape Efficient Health Systems en Route to UHC - Lessons from Two Continents.Corruption of pharmaceutical markets: addressing the misalignment of financial incentives and public health.Reference pricing and price negotiations for innovative new drugs : viable policies in the long term?
P2860

Reimbursement of pharmaceuticals: reference pricing versus health technology assessment.

Item
http://www.wikidata.org/entity/Q34804377
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Reimbursement of pharmaceuticals: reference pricing versus health technology assessment.
@ast
Reimbursement of pharmaceuticals: reference pricing versus health technology assessment.
@en
Reimbursement of pharmaceuticals: reference pricing versus health technology assessment.
@nl
type
label
Reimbursement of pharmaceuticals: reference pricing versus health technology assessment.
@ast
Reimbursement of pharmaceuticals: reference pricing versus health technology assessment.
@en
Reimbursement of pharmaceuticals: reference pricing versus health technology assessment.
@nl
prefLabel
Reimbursement of pharmaceuticals: reference pricing versus health technology assessment.
@ast
Reimbursement of pharmaceuticals: reference pricing versus health technology assessment.
@en
Reimbursement of pharmaceuticals: reference pricing versus health technology assessment.
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P5875
P698
P932
P356
P1433
P1476
Reimbursement of pharmaceuticals: reference pricing versus health technology assessment.
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P5875
P698
P932